Tighter Clinical Practices Near For Device Trials In China
This article was originally published in PharmAsia News
Executive Summary
Sites in China that undertake studies of medical devices will have to keep all clinical data and materials for a period of 10 years after the completion of a study, according to tighter GCP provisions that are due to take effect in the country from June.